Novartis Cosentyx® shows superior improvements in psoriasis patients’ quality of life versus Janssen’s IL-23 Stelara®*

NEXT STORY
Inivata Receives Medicare Final Coverage Decision for InVisionFirstTM-Lung Liquid Biopsy Test in Advanced Non-Small Cell Lung Cancer
PREV STORY
Darolutamide submitted for marketing authorization in Japan
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Coherus BioSciences to Report First Quarter 2017 Financial Results on May 8th

REDWOOD CITY, Calif., April 24, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...

author_avatar
NASDAQ Market News

Aduro Biotech and UC Berkeley Launch Industry-Leading Immunotherapeutics and Vaccine Research Initiative

Collaboration to Accelerate Breakthroughs in the Treatment and Prevention of Cancer, Infectious and Autoimmune ...

author_avatar
NASDAQ Market News

CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business Update

- On track to begin first company-sponsored clinical trial of a CRISPR-based therapeutic -- ...

author_avatar
NASDAQ Market News